| Literature DB >> 28886384 |
Lisa Mirabello1, Meredith Yeager2, Kai Yu3, Gary M Clifford4, Yanzi Xiao3, Bin Zhu3, Michael Cullen2, Joseph F Boland2, Nicolas Wentzensen3, Chase W Nelson5, Tina Raine-Bennett6, Zigui Chen7, Sara Bass2, Lei Song2, Qi Yang2, Mia Steinberg2, Laurie Burdett2, Michael Dean3, David Roberson2, Jason Mitchell2, Thomas Lorey8, Silvia Franceschi4, Philip E Castle9, Joan Walker10, Rosemary Zuna10, Aimée R Kreimer3, Daniel C Beachler11, Allan Hildesheim3, Paula Gonzalez12, Carolina Porras12, Robert D Burk13, Mark Schiffman3.
Abstract
Although most cervical human papillomavirus type 16 (HPV16) infections become undetectable within 1-2 years, persistent HPV16 causes half of all cervical cancers. We used a novel HPV whole-genome sequencing technique to evaluate an exceptionally large collection of 5,570 HPV16-infected case-control samples to determine whether viral genetic variation influences risk of cervical precancer and cancer. We observed thousands of unique HPV16 genomes; very few women shared the identical HPV16 sequence, which should stimulate a careful re-evaluation of the clinical implications of HPV mutation rates, transmission, clearance, and persistence. In case-control analyses, HPV16 in the controls had significantly more amino acid changing variants throughout the genome. Strikingly, E7 was devoid of variants in precancers/cancers compared to higher levels in the controls; we confirmed this in cancers from around the world. Strict conservation of the 98 amino acids of E7, which disrupts Rb function, is critical for HPV16 carcinogenesis, presenting a highly specific target for etiologic and therapeutic research. Published by Elsevier Inc.Entities:
Keywords: E7 gene; HPV epidemiology; HPV genomics; HPV16; cervical carcinogenesis
Mesh:
Substances:
Year: 2017 PMID: 28886384 PMCID: PMC5674785 DOI: 10.1016/j.cell.2017.08.001
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582